| Business Summary | | Insmed
Incorporated
is
a
biopharmaceutical
company
focused
on
the
development
of
products
to
treat
metabolic
and
endocrine-related
conditions.
The
Company
is
currently
developing
INS-1,
a
naturally
occurring,
orally-active
insulin
sensitizer.
It
is
being
developed
for
Type
2
diabetes
and
Polycystic
Ovary
Syndrome
(PCOS).
To
date
in
clinical
trials,
INS-1
has
improved
both
ovulation
rates
in
women
with
PCOS
as
well
as
glycemic
and
lipid
profiles
in
patients
with
Type
2
diabetes.
INS-1
is
currently
in
Phase
II
clinical
trials.
The
Company
is
also
developing
SomatoKine.
Currently
in
Phase
II
clinical
trials,
SomatoKine
is
a
human
recombinant
equivalent
to
the
naturally
occurring
complex
of
the
hormone,
insulin-like
growth
factor-I
(IGF-I)
and
its
primary
binding
protein
(IGFBP3).
Results
from
a
Phase
II
study
indicate
SomatoKine
has
the
potential
to
amplify
bone
repair
metabolism
and
functional
recovery
following
hip
fracture. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Insmed
Incorporated
is
a
biopharmaceutical
company
focused
on
the
development
of
products
to
treat
metabolic
and
endocrine-related
conditions,
and
is
currently
developing
an
orally-active
insulin
sensitizer.
For
the
six
months
ended
6/30/01,
revenues
rose
88%
to
$169
thousand.
Net
loss
fell
72%
to
$18.9
million.
Results
reflect
initial
license
fees
from
Taisho,
partially
offset
by
increased
clinical
trial
and
INS-1
manufacturing
costs. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Geoffrey Allan, Ph.D., 47 Chairman,
Pres, CEO | $714K | $674K | Michael Baer, 56 CFO | 270K | 54K | Robert Falconer, 48 VP
Technical Operations | 196K | 52K | Ronald Gunn, 40 VP-Bus.
Devel. | 246K | 401K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|